Clinical Study
|
Open Access
Featured
-
-
Epidemiology
| Open AccessNon-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case–control study
- M C Bradley
- , C M Hughes
- & L J Murray
-
Epidemiology
| Open AccessCumulative incidence trends of selected cancer sites in a Philippine population from 1983 to 2002: a joinpoint analysis
- V M Medina
- , A Laudico
- & M T Redaniel
-
Clinical Study
| Open AccessImpact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result
- R C Macefield
- , C Metcalfe
- & K Vedhara
-
Letter to the Editor
| Open AccessOngoing under-reporting of clinically relevant safety data in phase II studies of tyrosine kinase inhibitors
- P Schöffski
- , D H Garfield
- & P Wolter
-
Letter to the Editor
| Open AccessReply: Ongoing under-reporting of clinically relevant safety data in phase II studies of tyrosine kinase inhibitors
- S Novello
- , G V Scagliotti
- & R Govindan
-
Epidemiology
| Open AccessLong-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study
- D Mesher
- , A Szarewski
- & J Cuzick
-
Translational Therapeutics
| Open AccessThree dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer
- N M A White
- , T-F F Chow
- & G M Yousef
-
Epidemiology
| Open AccessAge of mother and grandmother in relation to a subject's breast cancer risk
- M C de Haan
- , K B Michels
- & Y T van der Schouw
-
Short Communication
| Open AccessRisks of second primary cancer among patients with major histological types of lung cancers in both men and women
- S-C Chuang
- , G Scélo
- & M Hashibe
-
Clinical Study
| Open AccessMegestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care
- N Penel
- , S Clisant
- & A Adenis
-
Molecular Diagnostics
| Open AccessOvarian cancer stem-like side-population cells are tumourigenic and chemoresistant
- L Hu
- , C McArthur
- & R B Jaffe
-
Translational Therapeutics
| Open AccessOncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa
- M T de Bruijn
- , D A E Raats
- & O Kranenburg
-
Genetics and Genomics
| Open AccessCommon germ-line polymorphism of C1QA and breast cancer survival
- E M Azzato
- , A J X Lee
- & A T Maia
-
Molecular Diagnostics
| Open AccessExpansion of CD133+ colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery
- D D Fang
- , Y J Kim
- & P A Moore
-
Translational Therapeutics
| Open Accessα-Tocopheryl succinate promotes selective cell death induced by vitamin K3 in combination with ascorbate
- M Tomasetti
- , E Strafella
- & R Guerrieri
-
Mini Review
| Open AccessLysophosphatidic acid production and action: critical new players in breast cancer initiation and progression
- N Panupinthu
- , H Y Lee
- & G B Mills
-
Molecular Diagnostics
| Open AccessMembrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis
- N Walsh
- , S Kennedy
- & L O'Driscoll
-
Molecular Diagnostics
| Open AccessHigh-resolution genomic profiling of human papillomavirus-associated vulval neoplasia
- K J Purdie
- , C A Harwood
- & C M Proby
-
Molecular Diagnostics
| Open AccessCirculating microRNAs in plasma of patients with gastric cancers
- M Tsujiura
- , D Ichikawa
- & E Otsuji
-
Translational Therapeutics
| Open AccessMitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients
- C Montagut
- , M Iglesias
- & J Albanell
-
Translational Therapeutics
| Open AccessFibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration
- G Sonvilla
- , S Allerstorfer
- & B Marian
-
Clinical Study
| Open AccessLong-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status
- D G R Evans
- , A Moran
- & F Lalloo
-
Clinical Study
| Open AccessChemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
- N C Turner
- , S J Strauss
- & T Meyer
-
Clinical Study
| Open AccessFlexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer
- B Gagnon
- , M Abrahamowicz
- & D Small
-
Translational Therapeutics
| Open AccessPhase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia
- S Daayana
- , E Elkord
- & H C Kitchener
-
Molecular Diagnostics
| Open AccessPleural fluid analysis of lung cancer vs benign inflammatory disease patients
- R Kremer
- , L A Best
- & R M Nagler
-
Molecular Diagnostics
| Open AccessHierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-κB signalling pathway and prognostic significance in prostate cancer
- I H Koumakpayi
- , C Le Page
- & F Saad
-
Clinical Study
| Open AccessOxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis
- R Zarate
- , J Rodríguez
- & J Gacía-Foncillas
-
Short Communication
| Open AccessAdenovirus DNA in Guthrie cards from children who develop acute lymphoblastic leukaemia (ALL)
- E Honkaniemi
- , G Talekar
- & B Gustafsson
-
Molecular Diagnostics
| Open AccessHigh frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management
- J Dômont
- , S Salas
- & J Bénard
-
Molecular Diagnostics
| Open AccessThe G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells
- J Huang
- , K Chen
- & J M Wang
-
Clinical Study
| Open AccessAre GPs under-investigating older patients presenting with symptoms of ovarian cancer? Observational study using General Practice Research Database
- A R Tate
- , A Nicholson
- & J A Cassell
-
Molecular Diagnostics
| Open AccessHigh expression of gabarapl1 is associated with a better outcome for patients with lymph node-positive breast cancer
- A Berthier
- , S Seguin
- & F Descotes
-
Clinical Study
| Open AccessPreferences for colorectal cancer screening strategies: a discrete choice experiment
- L Hol
- , E W de Bekker-Grob
- & M L Essink-Bot
-
Genetics and Genomics
| Open AccessGene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile
- K Graham
- , A de las Morenas
- & C L Rosenberg
-
Clinical Study
| Open AccessA comprehensive evaluation of the accuracy of cervical pre-cancer detection methods in a high-risk area in East Congo
- S Hovland
- , M Arbyn
- & F Karlsen
-
Letter to the Editor
| Open AccessImatinib plasma levels: correlation with clinical benefit in GIST patients
- N Widmer
- , L A Decosterd
- & T Buclin
-
Translational Therapeutics
| Open AccessInfluence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide
- J Bray
- , J Sludden
- & A V Boddy
-
Molecular Diagnostics
| Open Access‘Desperate house genes’: the dramatic example of hypoxia
- J Caradec
- , N Sirab
- & S Loric
-
Clinical Study
| Open AccessTreatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases – the UK experience
- S Sutherland
- , S Ashley
- & S R D Johnston
-
Letter to the Editor
| Open AccessReply: KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?
- C Cremolini
- , A Ruzzo
- & F Loupakis
-
-
Letter to the Editor
| Open AccessKRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?
- E Lopez-Crapez
- , L Mineur
- & P-J Lamy
-
Letter to the Editor
| Open AccessLoss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer
- C Mao
- , R-Y Liao
- & Q Chen
-
-
Molecular Diagnostics
| Open AccessNUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation
- T Hosono
- , T Tanaka
- & T Kamitani
-
Genetics and Genomics
| Open AccessMutSβ exceeds MutSα in dinucleotide loop repair
- J Kantelinen
- , M Kansikas
- & M Nyström
-
Clinical Study
| Open AccessThe management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l−1
- S McGrath
- , D Short
- & M J Seckl
-
Translational Therapeutics
| Open AccessPopulation pharmacokinetics of the humanised monoclonal antibody, HuHMFG1 (AS1402), derived from a phase I study on breast cancer
- B Royer
- , W Yin
- & X Pivot
Browse narrower subjects
- Biochemistry
- Biological techniques
- Biophysics
- Biotechnology
- Cancer
- Cell biology
- Chemical biology
- Computational biology and bioinformatics
- Developmental biology
- Drug discovery
- Ecology
- Evolution
- Genetics
- Immunology
- Microbiology
- Molecular biology
- Neuroscience
- Physiology
- Plant sciences
- Psychology
- Stem cells
- Structural biology
- Systems biology
- Zoology